Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+50Malignant Bladder Neoplasm+23.3Cutaneous Melanoma+20Malignant Laryngeal Neoplasm+16.7Malignant Pancreatic Neoplasm+16.7Malignant Vulvar Neoplasm+10Malignant Rectal Neoplasm+6.7Malignant Kidney Neoplasm+6.6Malignant Esophageal Neoplasm+3.4Malignant Anal Neoplasm+3.4Malignant Salivary Gland Neop…+3.3Malignant Testicular Neoplasm+3.3Malignant Vaginal Neoplasm+3.3Malignant Mesothelioma+3.3Malignant Liver Neoplasm0
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+50100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
40431
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
90
activityPercentile
40

ranking row 2606921

2▲2Malignant Bladder Neoplasm+23.396.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
17334
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
70
activityPercentile
46.7

ranking row 2606922

3=Cutaneous Melanoma+2093.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
8243
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
46.7
activityPercentile
26.7

ranking row 2606923

4▲1Malignant Laryngeal Neoplasm+16.790Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3933
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
36.7
activityPercentile
20

ranking row 2606925

4▲2Malignant Pancreatic Neoplasm+16.790Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
48323
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
96.7
activityPercentile
80

ranking row 2606924

6▲3Malignant Vulvar Neoplasm+1083.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1550
formula
percentile(mortality_count) − percentile(active_trials)
activity
54
burdenPercentile
23.3
activityPercentile
13.3

ranking row 2606926

7▲4Malignant Rectal Neoplasm+6.780Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12536
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
56.7
activityPercentile
50

ranking row 2606927

8▲2Malignant Kidney Neoplasm+6.676.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
14488
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
63.3
activityPercentile
56.7

ranking row 2606928

9▲3Malignant Esophageal Neoplasm+3.473.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
16014
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
66.7
activityPercentile
63.3

ranking row 2606929

10▲4Malignant Anal Neoplasm+3.470Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1600
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
26.7
activityPercentile
23.3

ranking row 2606930

11▲3Malignant Salivary Gland Neoplasm+3.366.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1104
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
20
activityPercentile
16.7

ranking row 2606931

12▲2Malignant Testicular Neoplasm+3.363.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
510
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
10
activityPercentile
6.7

ranking row 2606932

12▲1Malignant Vaginal Neoplasm+3.363.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
434
formula
percentile(mortality_count) − percentile(active_trials)
activity
31
burdenPercentile
3.3
activityPercentile
0

ranking row 2606933

14=Malignant Mesothelioma+3.356.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2236
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
33.3
activityPercentile
30

ranking row 2606934

15▼1Malignant Liver Neoplasm053.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
28937
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
83.3
activityPercentile
83.3

ranking row 2606936

15▼1Malignant Lung Neoplasm053.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
131888
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2606935

15▼1Malignant Prostate Neoplasm053.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
33363
formula
percentile(mortality_count) − percentile(active_trials)
activity
1375
burdenPercentile
86.7
activityPercentile
86.7

ranking row 2606937

18▲13Malignant Thyroid Gland Neoplasm-3.343.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2204
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
30
activityPercentile
33.3

ranking row 2606938

19▲6Malignant Hypopharyngeal Neoplasm-3.340Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
490
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
6.7
activityPercentile
10

ranking row 2606939

20▲2Malignant Breast Neoplasm-3.436.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
42672
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
93.3
activityPercentile
96.7

ranking row 2606940

20▲4Malignant Central Nervous System Neoplasm-3.436.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
17937
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
73.3
activityPercentile
76.7

ranking row 2606941

22▲4Malignant Penile Neoplasm-6.730Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
361
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
0
activityPercentile
6.7

ranking row 2606942

23▲3Leukemia-1026.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
23496
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
80
activityPercentile
90

ranking row 2606943

23▲5Malignant Ovarian Neoplasm-1026.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
13214
formula
percentile(mortality_count) − percentile(active_trials)
activity
684
burdenPercentile
60
activityPercentile
70

ranking row 2606944

23▲6Malignant Uterine Corpus Neoplasm-1026.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
7751
formula
percentile(mortality_count) − percentile(active_trials)
activity
411
burdenPercentile
43.3
activityPercentile
53.3

ranking row 2606945

26▲5Non-Hodgkin Lymphoma-16.616.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
19794
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
76.7
activityPercentile
93.3

ranking row 2606946

27▲6Malignant Gastric Neoplasm-16.713.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
10852
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
50
activityPercentile
66.7

ranking row 2606947

28▲6Malignant Cervical Neoplasm-2010Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4051
formula
percentile(mortality_count) − percentile(active_trials)
activity
505
burdenPercentile
40
activityPercentile
60

ranking row 2606949

28▲2Multiple Myeloma-2010Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12078
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
53.3
activityPercentile
73.3

ranking row 2606948

30▲5Hodgkin Lymphoma-203.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1056
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
16.7
activityPercentile
36.7

ranking row 2606950

31▲5Malignant Nasopharyngeal Neoplasm-300Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
686
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
13.3
activityPercentile
43.3

ranking row 2606951

Data updated 16 hours agoSource updated unknown31 eligible entities · inputs hash 14c2f4c76893f07853ff87fb